Use of Continuous Glucose Monitoring and Insulin Pump Technologies in People With Type 2 Diabetes: Insights From a Survey of Health Care Professionals and Patients in Germany, Austria, and Switzerland
Authors' conclusion
The findings indicate growing openness toward diabetes technologies among PWT2D and broader perceived indications among HCPs. However, uptake remains limited, particularly outside of intensive insulin therapy.
Study context
- Population
- Health care professionals and people with T2D from the DACH region (Germany, Austria, Switzerland), dt-report 2025survey, DACH region
- Participants
- 1,078 vs 450
- Exposure
- Health care professionals (HCPs) vs PWT2D
- HCPsn = 1,078
- PWT2Dn = 450
- Outcome
- Use of diabetes technology among survey participants
Methodological detailssurvey, Survey November–December 2025; frequencies of specific responses analysed
- Survey
- Survey November–December 2025; frequencies of specific responses analysed
Main finding
As reported in the abstract
- Survey participants using a continuous glucose monitoring (CGM)
- 58%
- Survey participants using a pump
- 1%
- HCP-estimated share of PWT2D on intensive insulin therapy who would benefit from CGM
- 87%
- HCP-perceived CGM indication among non-intensive insulin users
- 62%
- HCP-perceived CGM indication among those on oral therapies
- 55%
Observational data: associations, not effects.
Further findings
Reported barriers
- Lack of awareness, reimbursement limitations, digital literacy and usability concerns
Original publication
Use of Continuous Glucose Monitoring and Insulin Pump Technologies in People With Type 2 Diabetes: Insights From a Survey of Health Care Professionals and Patients in Germany, Austria, and Switzerland. J Diabetes Sci Technol. Published 6 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →